Aurobindo Pharma acquires Veritaz formulation biz for Rs 171 crore

Veritaz had a turnover of Rs 133 crore for the nine-month period ended December 2021 and it had a turnover of Rs 127 crore for the full year FY21.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MrDK6p8
via IFTTT

0 comments:

Post a Comment